Novartis appoints Elizabeth Barrett as Oncology Head
(WorldNews Europe)

Novartis appoints experienced pharmaceuticals industry leader with strong marketing skills to drive oncology business further Novartis appoints ad interim leader for its Global Drug Development organization Basel, January 11, 2018- Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the Executive Committee of Novartis, effective February 1, 2018. She will be based in Basel. Mrs. Barrett succeeds Bruno Strigini who decided to retire from Novartis for personal reasons. Vasant (Vas) Narasimhan, designated CEO of Novartis, said: `Liz is a highly accomplished and recognized oncology...